Palbociclib induces activation of AMPK and inhibits hepatocellular carcinoma in a CDK4/6-independent manner
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Palbociclib induces activation of AMPK and inhibits hepatocellular carcinoma in a CDK4/6-independent manner
Authors
Keywords
-
Journal
Molecular Oncology
Volume 11, Issue 8, Pages 1035-1049
Publisher
Wiley
Online
2017-04-28
DOI
10.1002/1878-0261.12072
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma
- (2016) Julien Bollard et al. GUT
- Chemoproteomics Reveals Novel Protein and Lipid Kinase Targets of Clinical CDK4/6 Inhibitors in Lung Cancer
- (2015) Natalia J. Sumi et al. ACS Chemical Biology
- The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
- (2015) Richard S Finn et al. LANCET ONCOLOGY
- The history and future of targeting cyclin-dependent kinases in cancer therapy
- (2015) Uzma Asghar et al. NATURE REVIEWS DRUG DISCOVERY
- Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway
- (2015) Ge Qin et al. Oncotarget
- Targeting AMPK for cancer prevention and treatment
- (2015) Weidong Li et al. Oncotarget
- Knockdown of PPP5C Inhibits Growth of Hepatocellular Carcinoma Cells In Vitro
- (2014) Liang Feng et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Berberine-induced apoptotic and autophagic death of HepG2 cells requires AMPK activation
- (2014) Rong Yu et al. Cancer Cell International
- AMP-Activated Protein Kinase Suppresses the In Vitro and In Vivo Proliferation of Hepatocellular Carcinoma
- (2014) Jidong Cheng et al. PLoS One
- Prognostic Significance of AMPK Activation and Therapeutic Effects of Metformin in Hepatocellular Carcinoma
- (2013) L. Zheng et al. CLINICAL CANCER RESEARCH
- Long-Term Outcome of the First 150 Liver Transplant Recipients: A Single-Center Experience
- (2013) S.N. Sintra et al. TRANSPLANTATION PROCEEDINGS
- Trends in Liver Cancer Mortality Rates in Japan, USA, UK, France and Korea Based on the WHO Mortality Database
- (2012) T. Matsuda et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- S100 Proteins Modulate Protein Phosphatase 5 Function
- (2012) Fuminori Yamaguchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Risk stratification for hepatitis B virus related hepatocellular carcinoma
- (2012) Chih-Lin Lin et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- AMPK: a nutrient and energy sensor that maintains energy homeostasis
- (2012) D. Grahame Hardie et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)
- (2011) G K Schwartz et al. BRITISH JOURNAL OF CANCER
- Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer
- (2011) Gottfried E. Konecny et al. CLINICAL CANCER RESEARCH
- AMPK Is a Direct Adenylate Charge-Regulated Protein Kinase
- (2011) J. S. Oakhill et al. SCIENCE
- Specific expression of osteopontin and S100A6 in hepatocellular carcinoma
- (2011) Zhan Hua et al. SURGERY
- Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts
- (2010) K. Michaud et al. CANCER RESEARCH
- Ppm1E is an in cellulo AMP-activated protein kinase phosphatase
- (2010) Martin Voss et al. CELLULAR SIGNALLING
- The PP1-R6 protein phosphatase holoenzyme is involved in the glucose-induced dephosphorylation and inactivation of AMP-activated protein kinase, a key regulator of insulin secretion, in MIN6 β cells
- (2010) Luisa Garcia-Haro et al. FASEB JOURNAL
- AMPK as a metabolic tumor suppressor: control of metabolism and cell growth
- (2010) Zhijun Luo et al. Future Oncology
- Proliferative Suppression by CDK4/6 Inhibition: Complex Function of the Retinoblastoma Pathway in Liver Tissue and Hepatoma Cells
- (2010) Dayana B. Rivadeneira et al. GASTROENTEROLOGY
- Quantitative analysis of PD 0332991 in xenograft mouse tumor tissue by a 96-well supported liquid extraction format and liquid chromatography/mass spectrometry
- (2010) Leslie Nguyen et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure
- (2010) J L Dean et al. ONCOGENE
- -Subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP-activated protein kinase (AMPK)
- (2010) J. S. Oakhill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protein Phosphatase 5 Regulates the Function of 53BP1 after Neocarzinostatin-induced DNA Damage
- (2009) Yoonsung Kang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AMPK in Health and Disease
- (2009) Gregory R. Steinberg et al. PHYSIOLOGICAL REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now